nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—SLC22A1—Estropipate—osteoporosis	0.168	0.347	CbGbCtD
Pramipexole—HTR2B—Raloxifene—osteoporosis	0.166	0.343	CbGbCtD
Pramipexole—SLC22A2—Estradiol—osteoporosis	0.0803	0.166	CbGbCtD
Pramipexole—SLC22A1—Estradiol—osteoporosis	0.0698	0.144	CbGbCtD
Pramipexole—Convulsion—Conjugated Estrogens—osteoporosis	0.000114	0.000266	CcSEcCtD
Pramipexole—Dry mouth—Zoledronate—osteoporosis	0.000114	0.000266	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000114	0.000266	CcSEcCtD
Pramipexole—Fatigue—Ethinyl Estradiol—osteoporosis	0.000114	0.000265	CcSEcCtD
Pramipexole—Pruritus—Alendronate—osteoporosis	0.000113	0.000264	CcSEcCtD
Pramipexole—Dyspepsia—Risedronate—osteoporosis	0.000113	0.000264	CcSEcCtD
Pramipexole—Eye disorder—Estradiol—osteoporosis	0.000113	0.000264	CcSEcCtD
Pramipexole—Tinnitus—Estradiol—osteoporosis	0.000113	0.000263	CcSEcCtD
Pramipexole—Constipation—Ethinyl Estradiol—osteoporosis	0.000113	0.000263	CcSEcCtD
Pramipexole—Confusional state—Zoledronate—osteoporosis	0.000113	0.000263	CcSEcCtD
Pramipexole—Hypersensitivity—Calcitriol—osteoporosis	0.000113	0.000262	CcSEcCtD
Pramipexole—Cardiac disorder—Estradiol—osteoporosis	0.000112	0.000262	CcSEcCtD
Pramipexole—Flushing—Estradiol—osteoporosis	0.000112	0.000262	CcSEcCtD
Pramipexole—Arthralgia—Conjugated Estrogens—osteoporosis	0.000112	0.000262	CcSEcCtD
Pramipexole—Chest pain—Conjugated Estrogens—osteoporosis	0.000112	0.000262	CcSEcCtD
Pramipexole—Myalgia—Conjugated Estrogens—osteoporosis	0.000112	0.000262	CcSEcCtD
Pramipexole—Asthenia—Ibandronate—osteoporosis	0.000112	0.000261	CcSEcCtD
Pramipexole—Anxiety—Conjugated Estrogens—osteoporosis	0.000112	0.000261	CcSEcCtD
Pramipexole—Nausea—Etidronic acid—osteoporosis	0.000112	0.000261	CcSEcCtD
Pramipexole—Oedema—Zoledronate—osteoporosis	0.000112	0.00026	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000111	0.00026	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000111	0.00026	CcSEcCtD
Pramipexole—Diarrhoea—Estropipate—osteoporosis	0.000111	0.00026	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Risedronate—osteoporosis	0.000111	0.000259	CcSEcCtD
Pramipexole—Infection—Zoledronate—osteoporosis	0.000111	0.000259	CcSEcCtD
Pramipexole—Fatigue—Risedronate—osteoporosis	0.000111	0.000259	CcSEcCtD
Pramipexole—Insomnia—Pamidronate—osteoporosis	0.000111	0.000258	CcSEcCtD
Pramipexole—Pruritus—Ibandronate—osteoporosis	0.00011	0.000257	CcSEcCtD
Pramipexole—Constipation—Risedronate—osteoporosis	0.00011	0.000256	CcSEcCtD
Pramipexole—Pain—Risedronate—osteoporosis	0.00011	0.000256	CcSEcCtD
Pramipexole—Angiopathy—Estradiol—osteoporosis	0.00011	0.000256	CcSEcCtD
Pramipexole—Shock—Zoledronate—osteoporosis	0.00011	0.000256	CcSEcCtD
Pramipexole—Paraesthesia—Pamidronate—osteoporosis	0.00011	0.000256	CcSEcCtD
Pramipexole—Diarrhoea—Alendronate—osteoporosis	0.00011	0.000256	CcSEcCtD
Pramipexole—Asthenia—Calcitriol—osteoporosis	0.00011	0.000256	CcSEcCtD
Pramipexole—Nervous system disorder—Zoledronate—osteoporosis	0.00011	0.000255	CcSEcCtD
Pramipexole—Immune system disorder—Estradiol—osteoporosis	0.000109	0.000255	CcSEcCtD
Pramipexole—Thrombocytopenia—Zoledronate—osteoporosis	0.000109	0.000255	CcSEcCtD
Pramipexole—Mediastinal disorder—Estradiol—osteoporosis	0.000109	0.000255	CcSEcCtD
Pramipexole—Dyspnoea—Pamidronate—osteoporosis	0.000109	0.000254	CcSEcCtD
Pramipexole—Tachycardia—Zoledronate—osteoporosis	0.000109	0.000254	CcSEcCtD
Pramipexole—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000109	0.000253	CcSEcCtD
Pramipexole—Chills—Estradiol—osteoporosis	0.000109	0.000253	CcSEcCtD
Pramipexole—Somnolence—Pamidronate—osteoporosis	0.000109	0.000253	CcSEcCtD
Pramipexole—Skin disorder—Zoledronate—osteoporosis	0.000108	0.000253	CcSEcCtD
Pramipexole—Pruritus—Calcitriol—osteoporosis	0.000108	0.000252	CcSEcCtD
Pramipexole—Hyperhidrosis—Zoledronate—osteoporosis	0.000108	0.000252	CcSEcCtD
Pramipexole—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000108	0.000252	CcSEcCtD
Pramipexole—Diarrhoea—Raloxifene—osteoporosis	0.000108	0.000252	CcSEcCtD
Pramipexole—Dyspepsia—Pamidronate—osteoporosis	0.000108	0.000251	CcSEcCtD
Pramipexole—Dizziness—Estropipate—osteoporosis	0.000108	0.000251	CcSEcCtD
Pramipexole—Oedema—Conjugated Estrogens—osteoporosis	0.000108	0.000251	CcSEcCtD
Pramipexole—Alopecia—Estradiol—osteoporosis	0.000107	0.00025	CcSEcCtD
Pramipexole—Infection—Conjugated Estrogens—osteoporosis	0.000107	0.000249	CcSEcCtD
Pramipexole—Diarrhoea—Ibandronate—osteoporosis	0.000107	0.000249	CcSEcCtD
Pramipexole—Anorexia—Zoledronate—osteoporosis	0.000106	0.000248	CcSEcCtD
Pramipexole—Decreased appetite—Pamidronate—osteoporosis	0.000106	0.000248	CcSEcCtD
Pramipexole—Mental disorder—Estradiol—osteoporosis	0.000106	0.000247	CcSEcCtD
Pramipexole—Dizziness—Alendronate—osteoporosis	0.000106	0.000247	CcSEcCtD
Pramipexole—Shock—Conjugated Estrogens—osteoporosis	0.000106	0.000247	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000106	0.000246	CcSEcCtD
Pramipexole—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000105	0.000246	CcSEcCtD
Pramipexole—Erythema—Estradiol—osteoporosis	0.000105	0.000246	CcSEcCtD
Pramipexole—Malnutrition—Estradiol—osteoporosis	0.000105	0.000246	CcSEcCtD
Pramipexole—Fatigue—Pamidronate—osteoporosis	0.000105	0.000246	CcSEcCtD
Pramipexole—Gastrointestinal pain—Risedronate—osteoporosis	0.000105	0.000245	CcSEcCtD
Pramipexole—Tachycardia—Conjugated Estrogens—osteoporosis	0.000105	0.000245	CcSEcCtD
Pramipexole—Urticaria—Ethinyl Estradiol—osteoporosis	0.000105	0.000244	CcSEcCtD
Pramipexole—Pain—Pamidronate—osteoporosis	0.000105	0.000244	CcSEcCtD
Pramipexole—Constipation—Pamidronate—osteoporosis	0.000105	0.000244	CcSEcCtD
Pramipexole—Diarrhoea—Calcitriol—osteoporosis	0.000105	0.000244	CcSEcCtD
Pramipexole—Skin disorder—Conjugated Estrogens—osteoporosis	0.000104	0.000244	CcSEcCtD
Pramipexole—Hypotension—Zoledronate—osteoporosis	0.000104	0.000243	CcSEcCtD
Pramipexole—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000104	0.000243	CcSEcCtD
Pramipexole—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000104	0.000243	CcSEcCtD
Pramipexole—Dizziness—Raloxifene—osteoporosis	0.000104	0.000243	CcSEcCtD
Pramipexole—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000104	0.000242	CcSEcCtD
Pramipexole—Flatulence—Estradiol—osteoporosis	0.000104	0.000242	CcSEcCtD
Pramipexole—Tension—Estradiol—osteoporosis	0.000103	0.000241	CcSEcCtD
Pramipexole—Vomiting—Estropipate—osteoporosis	0.000103	0.000241	CcSEcCtD
Pramipexole—Dysgeusia—Estradiol—osteoporosis	0.000103	0.000241	CcSEcCtD
Pramipexole—Dizziness—Ibandronate—osteoporosis	0.000103	0.000241	CcSEcCtD
Pramipexole—Rash—Estropipate—osteoporosis	0.000103	0.000239	CcSEcCtD
Pramipexole—Dermatitis—Estropipate—osteoporosis	0.000103	0.000239	CcSEcCtD
Pramipexole—Anorexia—Conjugated Estrogens—osteoporosis	0.000102	0.000239	CcSEcCtD
Pramipexole—Nervousness—Estradiol—osteoporosis	0.000102	0.000239	CcSEcCtD
Pramipexole—Urticaria—Risedronate—osteoporosis	0.000102	0.000238	CcSEcCtD
Pramipexole—Back pain—Estradiol—osteoporosis	0.000102	0.000238	CcSEcCtD
Pramipexole—Headache—Estropipate—osteoporosis	0.000102	0.000238	CcSEcCtD
Pramipexole—Vomiting—Alendronate—osteoporosis	0.000102	0.000238	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000102	0.000237	CcSEcCtD
Pramipexole—Abdominal pain—Risedronate—osteoporosis	0.000102	0.000237	CcSEcCtD
Pramipexole—Body temperature increased—Risedronate—osteoporosis	0.000102	0.000237	CcSEcCtD
Pramipexole—Muscle spasms—Estradiol—osteoporosis	0.000101	0.000236	CcSEcCtD
Pramipexole—Rash—Alendronate—osteoporosis	0.000101	0.000236	CcSEcCtD
Pramipexole—Insomnia—Zoledronate—osteoporosis	0.000101	0.000236	CcSEcCtD
Pramipexole—Dermatitis—Alendronate—osteoporosis	0.000101	0.000235	CcSEcCtD
Pramipexole—Feeling abnormal—Pamidronate—osteoporosis	0.000101	0.000235	CcSEcCtD
Pramipexole—Hypotension—Conjugated Estrogens—osteoporosis	0.0001	0.000234	CcSEcCtD
Pramipexole—Headache—Alendronate—osteoporosis	0.0001	0.000234	CcSEcCtD
Pramipexole—Paraesthesia—Zoledronate—osteoporosis	0.0001	0.000234	CcSEcCtD
Pramipexole—Vomiting—Raloxifene—osteoporosis	0.0001	0.000234	CcSEcCtD
Pramipexole—Gastrointestinal pain—Pamidronate—osteoporosis	0.0001	0.000233	CcSEcCtD
Pramipexole—Dyspnoea—Zoledronate—osteoporosis	9.96e-05	0.000232	CcSEcCtD
Pramipexole—Rash—Raloxifene—osteoporosis	9.94e-05	0.000232	CcSEcCtD
Pramipexole—Dermatitis—Raloxifene—osteoporosis	9.93e-05	0.000232	CcSEcCtD
Pramipexole—Somnolence—Zoledronate—osteoporosis	9.93e-05	0.000232	CcSEcCtD
Pramipexole—Vomiting—Ibandronate—osteoporosis	9.92e-05	0.000231	CcSEcCtD
Pramipexole—Tremor—Estradiol—osteoporosis	9.88e-05	0.00023	CcSEcCtD
Pramipexole—Headache—Raloxifene—osteoporosis	9.88e-05	0.00023	CcSEcCtD
Pramipexole—Rash—Ibandronate—osteoporosis	9.84e-05	0.000229	CcSEcCtD
Pramipexole—Dermatitis—Ibandronate—osteoporosis	9.83e-05	0.000229	CcSEcCtD
Pramipexole—Dyspepsia—Zoledronate—osteoporosis	9.83e-05	0.000229	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	9.8e-05	0.000228	CcSEcCtD
Pramipexole—Ill-defined disorder—Estradiol—osteoporosis	9.78e-05	0.000228	CcSEcCtD
Pramipexole—Headache—Ibandronate—osteoporosis	9.78e-05	0.000228	CcSEcCtD
Pramipexole—Insomnia—Conjugated Estrogens—osteoporosis	9.73e-05	0.000227	CcSEcCtD
Pramipexole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	9.72e-05	0.000227	CcSEcCtD
Pramipexole—Vomiting—Calcitriol—osteoporosis	9.71e-05	0.000227	CcSEcCtD
Pramipexole—Decreased appetite—Zoledronate—osteoporosis	9.71e-05	0.000226	CcSEcCtD
Pramipexole—Agitation—Estradiol—osteoporosis	9.69e-05	0.000226	CcSEcCtD
Pramipexole—Nausea—Estropipate—osteoporosis	9.67e-05	0.000225	CcSEcCtD
Pramipexole—Abdominal pain—Pamidronate—osteoporosis	9.66e-05	0.000225	CcSEcCtD
Pramipexole—Body temperature increased—Pamidronate—osteoporosis	9.66e-05	0.000225	CcSEcCtD
Pramipexole—Paraesthesia—Conjugated Estrogens—osteoporosis	9.66e-05	0.000225	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Zoledronate—osteoporosis	9.64e-05	0.000225	CcSEcCtD
Pramipexole—Rash—Calcitriol—osteoporosis	9.63e-05	0.000225	CcSEcCtD
Pramipexole—Fatigue—Zoledronate—osteoporosis	9.63e-05	0.000225	CcSEcCtD
Pramipexole—Dermatitis—Calcitriol—osteoporosis	9.62e-05	0.000224	CcSEcCtD
Pramipexole—Dyspnoea—Conjugated Estrogens—osteoporosis	9.59e-05	0.000224	CcSEcCtD
Pramipexole—Headache—Calcitriol—osteoporosis	9.57e-05	0.000223	CcSEcCtD
Pramipexole—Somnolence—Conjugated Estrogens—osteoporosis	9.56e-05	0.000223	CcSEcCtD
Pramipexole—Pain—Zoledronate—osteoporosis	9.55e-05	0.000223	CcSEcCtD
Pramipexole—Constipation—Zoledronate—osteoporosis	9.55e-05	0.000223	CcSEcCtD
Pramipexole—Nausea—Alendronate—osteoporosis	9.52e-05	0.000222	CcSEcCtD
Pramipexole—Malaise—Estradiol—osteoporosis	9.51e-05	0.000222	CcSEcCtD
Pramipexole—Hypersensitivity—Risedronate—osteoporosis	9.48e-05	0.000221	CcSEcCtD
Pramipexole—Vertigo—Estradiol—osteoporosis	9.47e-05	0.000221	CcSEcCtD
Pramipexole—Dyspepsia—Conjugated Estrogens—osteoporosis	9.47e-05	0.000221	CcSEcCtD
Pramipexole—Asthenia—Ethinyl Estradiol—osteoporosis	9.46e-05	0.000221	CcSEcCtD
Pramipexole—Syncope—Estradiol—osteoporosis	9.46e-05	0.000221	CcSEcCtD
Pramipexole—Nausea—Raloxifene—osteoporosis	9.36e-05	0.000218	CcSEcCtD
Pramipexole—Decreased appetite—Conjugated Estrogens—osteoporosis	9.35e-05	0.000218	CcSEcCtD
Pramipexole—Pruritus—Ethinyl Estradiol—osteoporosis	9.33e-05	0.000218	CcSEcCtD
Pramipexole—Palpitations—Estradiol—osteoporosis	9.32e-05	0.000217	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	9.28e-05	0.000216	CcSEcCtD
Pramipexole—Fatigue—Conjugated Estrogens—osteoporosis	9.27e-05	0.000216	CcSEcCtD
Pramipexole—Nausea—Ibandronate—osteoporosis	9.27e-05	0.000216	CcSEcCtD
Pramipexole—Loss of consciousness—Estradiol—osteoporosis	9.27e-05	0.000216	CcSEcCtD
Pramipexole—Asthenia—Risedronate—osteoporosis	9.23e-05	0.000215	CcSEcCtD
Pramipexole—Feeling abnormal—Zoledronate—osteoporosis	9.2e-05	0.000215	CcSEcCtD
Pramipexole—Cough—Estradiol—osteoporosis	9.2e-05	0.000215	CcSEcCtD
Pramipexole—Pain—Conjugated Estrogens—osteoporosis	9.2e-05	0.000214	CcSEcCtD
Pramipexole—Constipation—Conjugated Estrogens—osteoporosis	9.2e-05	0.000214	CcSEcCtD
Pramipexole—Gastrointestinal pain—Zoledronate—osteoporosis	9.13e-05	0.000213	CcSEcCtD
Pramipexole—Hypertension—Estradiol—osteoporosis	9.1e-05	0.000212	CcSEcCtD
Pramipexole—Pruritus—Risedronate—osteoporosis	9.1e-05	0.000212	CcSEcCtD
Pramipexole—Nausea—Calcitriol—osteoporosis	9.07e-05	0.000212	CcSEcCtD
Pramipexole—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.02e-05	0.00021	CcSEcCtD
Pramipexole—Hypersensitivity—Pamidronate—osteoporosis	9.01e-05	0.00021	CcSEcCtD
Pramipexole—Chest pain—Estradiol—osteoporosis	8.98e-05	0.000209	CcSEcCtD
Pramipexole—Arthralgia—Estradiol—osteoporosis	8.98e-05	0.000209	CcSEcCtD
Pramipexole—Myalgia—Estradiol—osteoporosis	8.98e-05	0.000209	CcSEcCtD
Pramipexole—Anxiety—Estradiol—osteoporosis	8.95e-05	0.000209	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	8.92e-05	0.000208	CcSEcCtD
Pramipexole—Urticaria—Zoledronate—osteoporosis	8.87e-05	0.000207	CcSEcCtD
Pramipexole—Discomfort—Estradiol—osteoporosis	8.87e-05	0.000207	CcSEcCtD
Pramipexole—Abdominal pain—Zoledronate—osteoporosis	8.83e-05	0.000206	CcSEcCtD
Pramipexole—Body temperature increased—Zoledronate—osteoporosis	8.83e-05	0.000206	CcSEcCtD
Pramipexole—Diarrhoea—Risedronate—osteoporosis	8.8e-05	0.000205	CcSEcCtD
Pramipexole—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	8.79e-05	0.000205	CcSEcCtD
Pramipexole—Dry mouth—Estradiol—osteoporosis	8.78e-05	0.000205	CcSEcCtD
Pramipexole—Asthenia—Pamidronate—osteoporosis	8.77e-05	0.000205	CcSEcCtD
Pramipexole—Dizziness—Ethinyl Estradiol—osteoporosis	8.72e-05	0.000203	CcSEcCtD
Pramipexole—Confusional state—Estradiol—osteoporosis	8.68e-05	0.000202	CcSEcCtD
Pramipexole—Pruritus—Pamidronate—osteoporosis	8.65e-05	0.000202	CcSEcCtD
Pramipexole—Oedema—Estradiol—osteoporosis	8.61e-05	0.000201	CcSEcCtD
Pramipexole—Infection—Estradiol—osteoporosis	8.55e-05	0.000199	CcSEcCtD
Pramipexole—Urticaria—Conjugated Estrogens—osteoporosis	8.54e-05	0.000199	CcSEcCtD
Pramipexole—Dizziness—Risedronate—osteoporosis	8.5e-05	0.000198	CcSEcCtD
Pramipexole—Body temperature increased—Conjugated Estrogens—osteoporosis	8.5e-05	0.000198	CcSEcCtD
Pramipexole—Abdominal pain—Conjugated Estrogens—osteoporosis	8.5e-05	0.000198	CcSEcCtD
Pramipexole—Shock—Estradiol—osteoporosis	8.47e-05	0.000197	CcSEcCtD
Pramipexole—Nervous system disorder—Estradiol—osteoporosis	8.44e-05	0.000197	CcSEcCtD
Pramipexole—Tachycardia—Estradiol—osteoporosis	8.4e-05	0.000196	CcSEcCtD
Pramipexole—Vomiting—Ethinyl Estradiol—osteoporosis	8.39e-05	0.000196	CcSEcCtD
Pramipexole—Diarrhoea—Pamidronate—osteoporosis	8.36e-05	0.000195	CcSEcCtD
Pramipexole—Skin disorder—Estradiol—osteoporosis	8.36e-05	0.000195	CcSEcCtD
Pramipexole—Hyperhidrosis—Estradiol—osteoporosis	8.32e-05	0.000194	CcSEcCtD
Pramipexole—Rash—Ethinyl Estradiol—osteoporosis	8.32e-05	0.000194	CcSEcCtD
Pramipexole—Dermatitis—Ethinyl Estradiol—osteoporosis	8.31e-05	0.000194	CcSEcCtD
Pramipexole—Headache—Ethinyl Estradiol—osteoporosis	8.26e-05	0.000193	CcSEcCtD
Pramipexole—Hypersensitivity—Zoledronate—osteoporosis	8.23e-05	0.000192	CcSEcCtD
Pramipexole—Vomiting—Risedronate—osteoporosis	8.18e-05	0.000191	CcSEcCtD
Pramipexole—Rash—Risedronate—osteoporosis	8.11e-05	0.000189	CcSEcCtD
Pramipexole—Dermatitis—Risedronate—osteoporosis	8.1e-05	0.000189	CcSEcCtD
Pramipexole—Dizziness—Pamidronate—osteoporosis	8.08e-05	0.000189	CcSEcCtD
Pramipexole—Headache—Risedronate—osteoporosis	8.06e-05	0.000188	CcSEcCtD
Pramipexole—Asthenia—Zoledronate—osteoporosis	8.01e-05	0.000187	CcSEcCtD
Pramipexole—Hypersensitivity—Conjugated Estrogens—osteoporosis	7.92e-05	0.000185	CcSEcCtD
Pramipexole—Pruritus—Zoledronate—osteoporosis	7.9e-05	0.000184	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Estradiol—osteoporosis	7.84e-05	0.000183	CcSEcCtD
Pramipexole—Nausea—Ethinyl Estradiol—osteoporosis	7.83e-05	0.000183	CcSEcCtD
Pramipexole—Insomnia—Estradiol—osteoporosis	7.78e-05	0.000182	CcSEcCtD
Pramipexole—Vomiting—Pamidronate—osteoporosis	7.77e-05	0.000181	CcSEcCtD
Pramipexole—Paraesthesia—Estradiol—osteoporosis	7.73e-05	0.00018	CcSEcCtD
Pramipexole—Asthenia—Conjugated Estrogens—osteoporosis	7.71e-05	0.00018	CcSEcCtD
Pramipexole—Rash—Pamidronate—osteoporosis	7.71e-05	0.00018	CcSEcCtD
Pramipexole—Dermatitis—Pamidronate—osteoporosis	7.7e-05	0.00018	CcSEcCtD
Pramipexole—Dyspnoea—Estradiol—osteoporosis	7.67e-05	0.000179	CcSEcCtD
Pramipexole—Headache—Pamidronate—osteoporosis	7.66e-05	0.000179	CcSEcCtD
Pramipexole—Somnolence—Estradiol—osteoporosis	7.65e-05	0.000178	CcSEcCtD
Pramipexole—Diarrhoea—Zoledronate—osteoporosis	7.64e-05	0.000178	CcSEcCtD
Pramipexole—Nausea—Risedronate—osteoporosis	7.64e-05	0.000178	CcSEcCtD
Pramipexole—Pruritus—Conjugated Estrogens—osteoporosis	7.61e-05	0.000177	CcSEcCtD
Pramipexole—Dyspepsia—Estradiol—osteoporosis	7.58e-05	0.000177	CcSEcCtD
Pramipexole—Decreased appetite—Estradiol—osteoporosis	7.48e-05	0.000174	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Estradiol—osteoporosis	7.43e-05	0.000173	CcSEcCtD
Pramipexole—Fatigue—Estradiol—osteoporosis	7.42e-05	0.000173	CcSEcCtD
Pramipexole—Dizziness—Zoledronate—osteoporosis	7.38e-05	0.000172	CcSEcCtD
Pramipexole—Pain—Estradiol—osteoporosis	7.36e-05	0.000172	CcSEcCtD
Pramipexole—Constipation—Estradiol—osteoporosis	7.36e-05	0.000172	CcSEcCtD
Pramipexole—Diarrhoea—Conjugated Estrogens—osteoporosis	7.36e-05	0.000172	CcSEcCtD
Pramipexole—Nausea—Pamidronate—osteoporosis	7.26e-05	0.000169	CcSEcCtD
Pramipexole—Dizziness—Conjugated Estrogens—osteoporosis	7.11e-05	0.000166	CcSEcCtD
Pramipexole—Vomiting—Zoledronate—osteoporosis	7.1e-05	0.000166	CcSEcCtD
Pramipexole—Feeling abnormal—Estradiol—osteoporosis	7.09e-05	0.000165	CcSEcCtD
Pramipexole—Rash—Zoledronate—osteoporosis	7.04e-05	0.000164	CcSEcCtD
Pramipexole—Gastrointestinal pain—Estradiol—osteoporosis	7.04e-05	0.000164	CcSEcCtD
Pramipexole—Dermatitis—Zoledronate—osteoporosis	7.03e-05	0.000164	CcSEcCtD
Pramipexole—Headache—Zoledronate—osteoporosis	7e-05	0.000163	CcSEcCtD
Pramipexole—Vomiting—Conjugated Estrogens—osteoporosis	6.84e-05	0.000159	CcSEcCtD
Pramipexole—Urticaria—Estradiol—osteoporosis	6.84e-05	0.000159	CcSEcCtD
Pramipexole—Abdominal pain—Estradiol—osteoporosis	6.8e-05	0.000159	CcSEcCtD
Pramipexole—Body temperature increased—Estradiol—osteoporosis	6.8e-05	0.000159	CcSEcCtD
Pramipexole—Rash—Conjugated Estrogens—osteoporosis	6.78e-05	0.000158	CcSEcCtD
Pramipexole—Dermatitis—Conjugated Estrogens—osteoporosis	6.77e-05	0.000158	CcSEcCtD
Pramipexole—Headache—Conjugated Estrogens—osteoporosis	6.74e-05	0.000157	CcSEcCtD
Pramipexole—Nausea—Zoledronate—osteoporosis	6.63e-05	0.000155	CcSEcCtD
Pramipexole—Nausea—Conjugated Estrogens—osteoporosis	6.39e-05	0.000149	CcSEcCtD
Pramipexole—Hypersensitivity—Estradiol—osteoporosis	6.34e-05	0.000148	CcSEcCtD
Pramipexole—Asthenia—Estradiol—osteoporosis	6.17e-05	0.000144	CcSEcCtD
Pramipexole—Pruritus—Estradiol—osteoporosis	6.09e-05	0.000142	CcSEcCtD
Pramipexole—Diarrhoea—Estradiol—osteoporosis	5.89e-05	0.000137	CcSEcCtD
Pramipexole—Dizziness—Estradiol—osteoporosis	5.69e-05	0.000133	CcSEcCtD
Pramipexole—Vomiting—Estradiol—osteoporosis	5.47e-05	0.000128	CcSEcCtD
Pramipexole—Rash—Estradiol—osteoporosis	5.43e-05	0.000127	CcSEcCtD
Pramipexole—Dermatitis—Estradiol—osteoporosis	5.42e-05	0.000126	CcSEcCtD
Pramipexole—Headache—Estradiol—osteoporosis	5.39e-05	0.000126	CcSEcCtD
Pramipexole—Nausea—Estradiol—osteoporosis	5.11e-05	0.000119	CcSEcCtD
Pramipexole—HTR1A—Signaling Pathways—CALCA—osteoporosis	2.1e-05	0.000241	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PTHLH—osteoporosis	2.1e-05	0.000241	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—BMP2—osteoporosis	2.1e-05	0.000241	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CALCA—osteoporosis	2.09e-05	0.00024	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6R—osteoporosis	2.09e-05	0.000239	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—WNT1—osteoporosis	2.08e-05	0.000238	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PTHLH—osteoporosis	2.06e-05	0.000237	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—BMP2—osteoporosis	2.06e-05	0.000237	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FGB—osteoporosis	2.05e-05	0.000235	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—POMC—osteoporosis	2.05e-05	0.000235	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—POMC—osteoporosis	2.04e-05	0.000234	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CALCA—osteoporosis	2.04e-05	0.000233	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CYP19A1—osteoporosis	2.03e-05	0.000233	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FGB—osteoporosis	2.02e-05	0.000232	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGA—osteoporosis	2.02e-05	0.000232	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ADCY5—osteoporosis	2.01e-05	0.00023	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IRS1—osteoporosis	2e-05	0.000229	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	1.99e-05	0.000228	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	1.99e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PSMA2—osteoporosis	1.98e-05	0.000227	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PSMA5—osteoporosis	1.98e-05	0.000227	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—KL—osteoporosis	1.98e-05	0.000227	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ADCY5—osteoporosis	1.96e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PSMA5—osteoporosis	1.95e-05	0.000224	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PSMA2—osteoporosis	1.95e-05	0.000224	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SPP1—osteoporosis	1.94e-05	0.000223	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TGFB1—osteoporosis	1.94e-05	0.000222	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ADCY5—osteoporosis	1.93e-05	0.000222	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—POMC—osteoporosis	1.93e-05	0.000221	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—POMC—osteoporosis	1.93e-05	0.000221	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—KL—osteoporosis	1.91e-05	0.000219	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—KL—osteoporosis	1.9e-05	0.000218	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.9e-05	0.000218	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	1.88e-05	0.000216	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6R—osteoporosis	1.88e-05	0.000216	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—BMP2—osteoporosis	1.88e-05	0.000215	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	1.88e-05	0.000215	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SPP1—osteoporosis	1.87e-05	0.000214	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.86e-05	0.000214	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—POMC—osteoporosis	1.85e-05	0.000213	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IGF1—osteoporosis	1.85e-05	0.000213	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—KL—osteoporosis	1.85e-05	0.000212	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CALCA—osteoporosis	1.85e-05	0.000212	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ADCY5—osteoporosis	1.85e-05	0.000212	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGB—osteoporosis	1.84e-05	0.000211	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.82e-05	0.000208	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CALCA—osteoporosis	1.82e-05	0.000208	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TGFB1—osteoporosis	1.81e-05	0.000208	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.81e-05	0.000207	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—POMC—osteoporosis	1.8e-05	0.000207	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—POMC—osteoporosis	1.8e-05	0.000207	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SPP1—osteoporosis	1.79e-05	0.000205	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ADCY5—osteoporosis	1.78e-05	0.000204	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GPX1—osteoporosis	1.77e-05	0.000203	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	1.77e-05	0.000203	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	1.77e-05	0.000203	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—POMC—osteoporosis	1.77e-05	0.000203	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	1.76e-05	0.000202	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.76e-05	0.000201	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ADCY5—osteoporosis	1.74e-05	0.0002	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ADCY5—osteoporosis	1.73e-05	0.000199	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GPX1—osteoporosis	1.73e-05	0.000198	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.72e-05	0.000197	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.72e-05	0.000197	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—LEP—osteoporosis	1.72e-05	0.000197	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ADCY5—osteoporosis	1.72e-05	0.000197	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IRS2—osteoporosis	1.69e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SPP1—osteoporosis	1.68e-05	0.000193	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—LEP—osteoporosis	1.68e-05	0.000193	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KL—osteoporosis	1.68e-05	0.000192	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SPP1—osteoporosis	1.66e-05	0.000191	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ADCY5—osteoporosis	1.66e-05	0.00019	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—LEP—osteoporosis	1.66e-05	0.00019	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GPX1—osteoporosis	1.65e-05	0.00019	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.65e-05	0.00019	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KL—osteoporosis	1.65e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.64e-05	0.000188	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—MTHFR—osteoporosis	1.64e-05	0.000188	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—POMC—osteoporosis	1.64e-05	0.000188	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.61e-05	0.000185	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.61e-05	0.000185	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.61e-05	0.000185	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.61e-05	0.000184	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.6e-05	0.000183	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—MTHFR—osteoporosis	1.59e-05	0.000183	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ESR1—osteoporosis	1.58e-05	0.000181	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—LEP—osteoporosis	1.58e-05	0.000181	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.57e-05	0.00018	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	1.55e-05	0.000178	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.53e-05	0.000176	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—MTHFR—osteoporosis	1.53e-05	0.000175	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IRS2—osteoporosis	1.52e-05	0.000175	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.51e-05	0.000173	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IRS2—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KL—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.5e-05	0.000172	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—LEP—osteoporosis	1.49e-05	0.000171	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.49e-05	0.000171	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IRS1—osteoporosis	1.48e-05	0.000169	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—POMC—osteoporosis	1.48e-05	0.000169	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.47e-05	0.000169	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—LEP—osteoporosis	1.47e-05	0.000169	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.46e-05	0.000168	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.45e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.45e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—POMC—osteoporosis	1.44e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.44e-05	0.000165	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.44e-05	0.000165	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.43e-05	0.000164	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000163	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—POMC—osteoporosis	1.42e-05	0.000163	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.42e-05	0.000163	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—osteoporosis	1.42e-05	0.000163	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.41e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.41e-05	0.000162	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ADCY5—osteoporosis	1.41e-05	0.000161	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ESR1—osteoporosis	1.4e-05	0.000161	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GPX1—osteoporosis	1.4e-05	0.000161	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.4e-05	0.000161	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6R—osteoporosis	1.39e-05	0.000159	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF1—osteoporosis	1.37e-05	0.000157	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—POMC—osteoporosis	1.36e-05	0.000156	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.36e-05	0.000156	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IRS1—osteoporosis	1.33e-05	0.000152	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.33e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.32e-05	0.000152	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.31e-05	0.000151	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IRS1—osteoporosis	1.31e-05	0.00015	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—POMC—osteoporosis	1.31e-05	0.00015	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.31e-05	0.00015	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.31e-05	0.00015	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.3e-05	0.000149	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—MTHFR—osteoporosis	1.29e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.29e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—LEP—osteoporosis	1.28e-05	0.000147	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—POMC—osteoporosis	1.28e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—LEP—osteoporosis	1.27e-05	0.000146	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—POMC—osteoporosis	1.27e-05	0.000146	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SPP1—osteoporosis	1.27e-05	0.000146	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.27e-05	0.000145	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.27e-05	0.000145	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—POMC—osteoporosis	1.26e-05	0.000145	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.25e-05	0.000143	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6R—osteoporosis	1.25e-05	0.000143	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.24e-05	0.000142	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6R—osteoporosis	1.23e-05	0.000141	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000141	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.22e-05	0.00014	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—POMC—osteoporosis	1.22e-05	0.00014	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.22e-05	0.00014	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1—osteoporosis	1.21e-05	0.000139	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.18e-05	0.000136	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.18e-05	0.000136	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.18e-05	0.000135	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IRS2—osteoporosis	1.15e-05	0.000132	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.14e-05	0.000131	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.14e-05	0.000131	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.14e-05	0.00013	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.14e-05	0.00013	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.13e-05	0.00013	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LEP—osteoporosis	1.12e-05	0.000129	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MYC—osteoporosis	1.11e-05	0.000128	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.11e-05	0.000128	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—osteoporosis	1.11e-05	0.000127	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LEP—osteoporosis	1.11e-05	0.000127	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.11e-05	0.000127	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—POMC—osteoporosis	1.1e-05	0.000126	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.1e-05	0.000126	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—POMC—osteoporosis	1.09e-05	0.000126	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.09e-05	0.000124	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ESR1—osteoporosis	1.07e-05	0.000123	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.07e-05	0.000123	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.07e-05	0.000122	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.07e-05	0.000122	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.06e-05	0.000122	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.06e-05	0.000121	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.06e-05	0.000121	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.05e-05	0.000121	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—osteoporosis	1.05e-05	0.00012	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.04e-05	0.000119	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—POMC—osteoporosis	1.03e-05	0.000119	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.03e-05	0.000118	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.02e-05	0.000117	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.01e-05	0.000115	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IRS1—osteoporosis	1e-05	0.000115	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—osteoporosis	9.98e-06	0.000114	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IRS1—osteoporosis	9.87e-06	0.000113	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—POMC—osteoporosis	9.66e-06	0.000111	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ESR1—osteoporosis	9.61e-06	0.00011	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—POMC—osteoporosis	9.51e-06	0.000109	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6R—osteoporosis	9.43e-06	0.000108	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—osteoporosis	9.42e-06	0.000108	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—osteoporosis	9.3e-06	0.000107	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—osteoporosis	9.29e-06	0.000107	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6R—osteoporosis	9.28e-06	0.000106	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—osteoporosis	9.15e-06	0.000105	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IRS1—osteoporosis	8.98e-06	0.000103	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—POMC—osteoporosis	8.65e-06	9.92e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MYC—osteoporosis	8.53e-06	9.78e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—osteoporosis	8.51e-06	9.76e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6R—osteoporosis	8.44e-06	9.68e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—osteoporosis	8.39e-06	9.62e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—osteoporosis	8.37e-06	9.6e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MYC—osteoporosis	8.35e-06	9.58e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—osteoporosis	8.33e-06	9.56e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—osteoporosis	8.32e-06	9.54e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MYC—osteoporosis	8.22e-06	9.43e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—osteoporosis	8.2e-06	9.4e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—osteoporosis	8.1e-06	9.29e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—osteoporosis	8.05e-06	9.24e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MYC—osteoporosis	7.85e-06	9e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—osteoporosis	7.83e-06	8.98e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—osteoporosis	7.83e-06	8.98e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MYC—osteoporosis	7.4e-06	8.49e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—osteoporosis	7.38e-06	8.46e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MYC—osteoporosis	7.3e-06	8.37e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—osteoporosis	7.28e-06	8.35e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—osteoporosis	7.11e-06	8.15e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—osteoporosis	6.99e-06	8.02e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MYC—osteoporosis	6.59e-06	7.56e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	6.57e-06	7.54e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—osteoporosis	6.41e-06	7.35e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—osteoporosis	6.36e-06	7.3e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MYC—osteoporosis	6.36e-06	7.3e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—osteoporosis	6.35e-06	7.28e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MYC—osteoporosis	6.33e-06	7.26e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—osteoporosis	6.31e-06	7.24e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—osteoporosis	6.28e-06	7.2e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—osteoporosis	6.18e-06	7.09e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MYC—osteoporosis	6.16e-06	7.06e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	6.14e-06	7.04e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—osteoporosis	5.9e-06	6.76e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MYC—osteoporosis	5.59e-06	6.41e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—osteoporosis	5.57e-06	6.39e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—osteoporosis	5.56e-06	6.38e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MYC—osteoporosis	5.5e-06	6.3e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—osteoporosis	5.49e-06	6.29e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—osteoporosis	5.48e-06	6.29e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MYC—osteoporosis	5e-06	5.73e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.99e-06	5.72e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—osteoporosis	4.95e-06	5.68e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—osteoporosis	4.78e-06	5.49e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—osteoporosis	4.76e-06	5.46e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—osteoporosis	4.63e-06	5.31e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—osteoporosis	4.2e-06	4.82e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—osteoporosis	4.13e-06	4.74e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.76e-06	4.31e-05	CbGpPWpGaD
